iScience (Nov 2021)

Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19

  • Christoph Schultheiß,
  • Lisa Paschold,
  • Edith Willscher,
  • Donjete Simnica,
  • Anna Wöstemeier,
  • Franziska Muscate,
  • Maxi Wass,
  • Stephan Eisenmann,
  • Jochen Dutzmann,
  • Gernot Keyßer,
  • Nicola Gagliani,
  • Mascha Binder

Journal volume & issue
Vol. 24, no. 11
p. 103325

Abstract

Read online

Summary: In parasite and viral infections, aberrant B cell responses can suppress germinal center reactions thereby blunting long-lived memory and may provoke immunopathology including autoimmunity. Using COVID-19 as model, we set out to identify serological, cellular, and transcriptomic imprints of pathological responses linked to autoreactive B cells at single-cell resolution. We show that excessive plasmablast expansions are prognostically adverse and correlate with autoantibody production but do not hinder the formation of neutralizing antibodies. Although plasmablasts followed interleukin-4 (IL-4) and BAFF-driven developmental trajectories, were polyclonal, and not enriched in autoreactive B cells, we identified two memory populations (CD80+/ISG15+ and CD11c+/SOX5+/T-bet+/−) with immunogenetic and transcriptional signs of autoreactivity that may be the cellular source of autoantibodies in COVID-19 and that may persist beyond recovery. Immunomodulatory interventions discouraging such adverse responses may be useful in selected patients to shift the balance from autoreactivity toward long-term memory.

Keywords